Diltiazem Pharmacology

Diltiazem, a non-dihydropyridine calcium channel blocker, functions by inhibiting calcium entry into voltage-gated channels, effectively lowering heart rate and blood pressure through smooth muscle relaxation. While commonly used for hypertension and atrial fibrillation, its clinical utility requires careful navigation of diverse dosage forms, which are not interchangeable and carry distinct pharmacokinetic profiles. Practitioners must monitor for dose-dependent adverse effects such as edema, constipation, and bradycardia to avoid the prescribing cascade. Furthermore, as a CYP3A4 inhibitor, Diltiazem necessitates cautious management when co-administered with medications like apixaban or simvastatin to prevent toxicity. Patients with existing left ventricular dysfunction should avoid this therapy, as it can exacerbate heart failure symptoms. Consistent monitoring of pulse and blood pressure remains essential to ensure patient safety and therapeutic efficacy when utilizing this medication in clinical practice.